Operating Income
Operating Income
Vertex Pharmaceuticals Operating Income decreased by 5.6% to $1.14B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 80.6%, from $630.10M to $1.14B. Over 3 years (FY 2021 to FY 2025), Operating Income shows an upward trend with a 14.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Income
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
Growth in operating income suggests that the core business is becoming more profitable and efficient.
Detailed definition
The profit realized from a business's own operations after deducting operating expenses like wages, depreciation, and co...
Peer comparison
This is a key metric for comparing the fundamental business performance of companies with different tax or debt structures.
Metric ID:
is_operating_incomeHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$37.96M | $1.05B | $877.72M | $1.04B | $1.11B | $1.13B | $1.03B | $779.00M | $1.03B | $1.04B | $988.50M | $1.14B | -$3.51B | $1.12B | $630.10M | $1.15B | $1.19B | $1.21B | $1.14B |
| QoQ Change | — | >999% | -16.8% | +18.6% | +6.3% | +1.8% | -8.3% | -24.6% | +31.8% | +1.1% | -4.8% | +15.3% | -408.4% | +131.8% | -43.6% | +82.7% | +3.0% | +1.7% | -5.6% |
| YoY Change | — | — | — | — | >999% | +6.8% | +17.7% | -25.2% | -7.2% | -7.9% | -4.4% | +46.3% | -442.4% | +7.5% | -44.7% | +132.8% | +6.3% | — | +80.6% |
Range-$3.51B – $1.21B
CAGR+112.9%
Avg YoY Growth+198.6%
Median YoY Growth+6.6%
Operating Income at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's operating income?
- Vertex Pharmaceuticals (VRTX) reported operating income of $1.14B in Q1 2026.
- How has Vertex Pharmaceuticals's operating income changed year-over-year?
- Vertex Pharmaceuticals's operating income increased by 80.6% year-over-year, from $630.10M to $1.14B.
- What is the long-term trend for Vertex Pharmaceuticals's operating income?
- Over 3 years (2021 to 2025), Vertex Pharmaceuticals's operating income has grown at a 14.5% compound annual growth rate (CAGR), from $2.78B to $4.17B.
- What does operating income mean?
- The profit earned from core business activities, before accounting for interest and taxes.